Becas Gilead a la investigación biomédica

Proyectos seleccionados

9ª Convocatoria de Becas Gilead a la Investigación Biomédica en VIH, COVID-19, Hepatitis Virales C y Delta, Infección Fúngica Invasora, Linfomas de estirpe B y Oncología Médica.

 
COVID:
 
Xavier Solanich Moreno             

Neutralizing autoantibodies against type I interferons continue to confer a higher risk of severe COVID-19 in fully vaccinated population?

Instituto De Investigación Biomédica De Bellvitge (Idibell)

 
Carlos Luis Parra Calderón

FLANDERS: Fast LeArniNg coviD 19 carE System

Fundación Pública Andaluza Para La Gestion De La Investigación En Salud De Sevilla
 
 
VIH:

Maria Jose Buzón Gomez           

Identification of HIV-latency markers in human tissues

Fundación Instituto De Investigación Valle De Hebrón

 
Jose Ramon Blanco Ramos        

loneliness and/or social isolation in persons living with hiv over 50 years old. Biomarkers signatures. Substudy

Fundación Seimc/Gesida

 
Norma Ibón Rallón Afanador    

Exosomes as triggers of non-AIDS-defining cancers development in the context of HIV pathogenesis

Fundación Instituto De Investigación Sanitaria Fundación Jimenez Diaz

 
Cesar Fernandez Sanchez       
    
Development of pioneering quantitative molecular diagnostic assays based on an innovative aptamer nanotechnological approach for high-throughput and point-of-care early diagnosis of HIV

Instituto Ramon Y Cajal De Investigación Sanitaria (Irycis)

 
Maria Pernas Escario    

Determination of factors associated with protection against Human Immunodeficiency VIrus type 1 Reinfection: Identification of protection correlates.

Instituto De Salud Carlos Iii, O.A., M.P

 
David Dalmau Juanola 

Monocytes imprints as predictors of cardiovascular risk in PLWH

Fundación Mutua De Terrassa

 
Ezequiel Ruiz-Mateos Carmona

Analysis of the quality of HIV-1 reservoir in persistent elite controllers and people on long-term cART, association with immune parameters.

Fundación Pública Andaluza Para La Gestion De La Investigación En Salud De Sevilla

 
Hepatitis:

Manuel Romero Gomez             

Pre-HepC: Predictor of hepatitis C in undiagnosed patients based on real-world evidence

Fundación Pública Andaluza Para La Gestion De La Investigación En Salud De Sevilla
 
Francisco Rodriguez Frías

Standard-HDV. Standardization of HDV-RNA quantification: a need that can no longer be ignored

Fundación Instituto De Investigación Valle De Hebrón
 
 
Hemato-Oncología/ Linfoma:

 
Mariana Bastos Oreiro

Dynamics of circulating tumor DNA and other biomarkers prior to infusion of CAR-T therapy as a prognostic marker of treatment failure in diffuse large B cell lymphoma

Fundación Investigación Biomédica Hospital Gregorio Marañón

 
Ana Fernandez Cruz      

A prospective multicenter study to determine the usefulness of systematic 18-FDG-PET-TC for the management of invasive fungal infection (PETIFI project)

Hospital Puerta De Hierro

 
Pedro Puerta Alcalde   

Real-life invasive fungal disease epidemiology in a tertiary center in Spain: new hosts and changing epidemiology

Fundacio Clinic Per A La Recerca Biomédica

 
Teresa Caballero Velázquez      

Prediction of car-t cell treatment response: searching for biomarkers

Instituto De Biomedicina De Sevilla - Ibis
 
 
Oncología Médica:

Albert Font Pous            

Comprehensive analysis of urine biomarkers to predict pathologic complete response in muscle-invasive bladder cancer patients treated with neoadjuvant therapy

Fundación Instituto Inv Germans Trias I Pujol

 
Beatriz Castelo Fernandez         

Identification of new biomarkers to predict patient progression in ductal salivary cancer

Fundación Investigación Biomédica Hospital La Paz

 
Juan Miguel Cejalvo Andujar    

The role of AXL in modulating tumor microenvironment as potential therapeutic strategy for HER2- positive breast cancer

Instituto De Investigación Sanitaria Incliva

 
Noelia Martinez Jañez 

Male Breast Cancer: molecular characterization for personalized clinical management of a rare disease

Fundación Grupo Español Investigación En Cancer De Mama (Geicam)
 

Tania Carolina Fleitas Kanonnikoff        

Prognostic and predictive impact of the microbiome and the tumor immune microenvironment on advanced gastric cancer across young patients (minors 50 YO): VERO-2 project.

Instituto De Investigación Sanitaria Incliva

 
Luis Manuel Manso Sanchez

Deep Learning and morphological patterns of Homologous Recombination Deficiency in ovarian cancers from whole slide images

Fundación Investigación Biomédica Hospital 12 De octubre